Injective could attract repeat traders and generate fees to support INJ buybacks and burns as it adds markets and trading tools. SICI is live for trading GPU rental prices; options for SICI, US indexes and commodities are on testnet, and developers can build options apps on the same infrastructure. BDACS is working to bring KRW1 settlement to its RWA markets, subject to regulatory approval. INJ deserves a place on the watchlist. x.com 

Injective looks primed to 2x or even 3x in a relatively short period, and 100% of its supply is already in circulation. x.com  x.com 

Injective's INJ is no longer attractive enough to compete with newer Layer 1 projects, in reply to @DukeD_Defi's case that the market misprices it as an onchain capital-markets chain. x.com 

Mid-cap layer-1 tokens Sui, Aptos, NEAR and Injective show strong recovery potential as capital rotates from bitcoin and ether into mid-cap L1s, a gradual rerating on real fundamentals, not a 2021-style pump. Sui has TVL above ~$745M and ~954 monthly active developers; Aptos has parallel execution and dev traction; NEAR logged ~314M Q1 transactions despite slowing activity; Injective launched real-time USDC settlement. Every bull cycle needs strong L1 activity, so L1s should move together soon. … Show more

NEAR can never be money, so any monetary or privacy premium ascribed to the token will flow to permissionless neutral protocols like Zcash and, to a lesser degree, Monero. NEAR's freezing of funds from the Bitget hack was the right business decision, but it shows that programmability creates governance surface area that is antithetical to money. The NEAR chain made about $150k in 30 days, Intents $1.7M and perps $61k, an insane multiple for something that isn't money. x.com  x.com  x.com 

NEAR looks headed higher, with quantum-ready accounts adding to its technology case: co-founder Illia Polosukhin says users can update their account keys to be post-quantum today without moving assets. x.com  x.com 

NEAR, Hyperliquid, Uniswap and Pump.fun benefit from the scarcity of quality crypto tokens, which is extremely bullish for the few that are actually good. With few good tokens, selection is easier, fewer positions are needed and more capital flows into the same winners. Per the quoted post, only about 20 projects generate around $50k+ in daily holder revenue. DefiIgnas adds that revenue tokens get less attractive the higher the price goes if revenue doesn't pick up. x.com  x.com 

NEAR's $2.4 billion market cap already prices it as a major AI and apps layer, so the success of NEAR Intents does not justify the valuation. Intents is a strong bridging product and handled over $200 million of volume in about a day, per @andyyy, but it earns only about $1.5 million in annualized revenue, and valuing NEAR as a bridge is not very bullish. This may be a midcurve take. x.com 

NEAR is an AI-native blockchain and a pioneer of chain abstraction, and its run from $1.90 to $4.27 is not done yet. x.com 

Ondo and Centrifuge are building the issuance, distribution, liquidity and asset-management rails that benefit as more assets move onchain, and their value does not yet reflect how fast the product layer is expanding. Tokenized stocks, at $2.46B of market cap, produced $808M of daily volume, about 60% of the total, while tokenized ETFs at $583M traded $163M, turnover close to stocks and almost 5x commodities. Robinhood leads now, but the opportunity should expand beyond one platform. x.com